Jan 31, 2024 / 11:00AM GMT
Nick Stone -
Hello, everyone. It's Nick Stone, Head of Investor Relations. Welcome to today's call and webcast. The presentation was sent to our distribution list by e-mail, and you can also find it on gsk.com.
Please turn to Slide 2. This is the usual safe harbor statement. We will comment on our performance using constant exchange rates, or CR unless stated otherwise. As a reminder, following the Consumer Healthcare demerger in 2022, we're presenting performance and growth at the continuing operations for GSK.
Please turn to Slide 3. Today's call will last approximately 1 hour with the presentation taking around 30 minutes and the remaining time for your questions. We request that you ask 1 to 2 questions so that everyone has a chance to participate.
Turning to Slide 4. I will now hand the call over to Emma.
Emma Natasha Walmsley - GSK plc - CEO & Director
Hello, and a warm welcome to everybody joining this call. Today, we are updating you on our performance for 2023, giving guidance for 2024, and providing you with new upgraded longer
Q4 2023 GSK plc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot